In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease
- PMID: 3335296
- DOI: 10.1016/0016-5085(88)90607-5
In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease
Abstract
Specific peptides of known amino acid sequence were prepared from alpha-gliadin (A-gliadin) by cleavage of the protein with cyanogen bromide and chymotrypsin and purification of the resulting peptides. The three peptides derived from the cyanogen bromide cleavage spanned the complete sequence of A-gliadin (266 residues). Four peptides derived from chymotryptic digestion covered the N-terminal sequence through residue 68. These peptides were tested for toxicity in celiac disease by organ culture of biopsied small intestinal tissues taken from patients with active celiac disease. Enterocyte height was used as a measure of peptide effect on cultured tissues. Five of seven peptides tested significantly inhibited increase of enterocyte height in the cultures and were considered toxic on this basis. The largest common sequences among the toxic peptides were -pro-ser-gln-gln- and -gln-gln-gln-pro-; these sequences were absent from the nontoxic peptides. The relationship of these sequences to the damaging effect of gliadins on the small intestinal mucosa in celiac disease remains to be investigated.
Similar articles
-
Effects of gliadin peptides B1-B4 in celiac disease. I. Organ culture studies.J Pediatr Gastroenterol Nutr. 1987 May-Jun;6(3):335-40. doi: 10.1097/00005176-198705000-00005. J Pediatr Gastroenterol Nutr. 1987. PMID: 3430242
-
Are all gliadins toxic in coeliac disease? An in vitro study of alpha, beta, gamma, and w gliadins.Scand J Gastroenterol. 1984 Jan;19(1):41-7. Scand J Gastroenterol. 1984. PMID: 6710076
-
Characterizing one of the DQ2 candidate epitopes in coeliac disease: A-gliadin 51-70 toxicity assessed using an organ culture system.Eur J Gastroenterol Hepatol. 2003 Dec;15(12):1293-8. doi: 10.1097/00042737-200312000-00007. Eur J Gastroenterol Hepatol. 2003. PMID: 14624152
-
Relation between gliadin structure and coeliac toxicity.Acta Paediatr Suppl. 1996 May;412:3-9. doi: 10.1111/j.1651-2227.1996.tb14239.x. Acta Paediatr Suppl. 1996. PMID: 8783747 Review.
-
The precipitating factor in coeliac disease.Baillieres Clin Gastroenterol. 1995 Jun;9(2):191-207. doi: 10.1016/0950-3528(95)90027-6. Baillieres Clin Gastroenterol. 1995. PMID: 7549024 Review.
Cited by
-
Coeliac disease: characterisation of monoclonal antibodies raised against a synthetic peptide corresponding to amino acid residues 206-217 of A-gliadin.Gut. 1992 Nov;33(11):1504-7. doi: 10.1136/gut.33.11.1504. Gut. 1992. PMID: 1280610 Free PMC article.
-
Cereal chemistry, molecular biology, and toxicity in coeliac disease.Gut. 1991 Sep;32(9):1055-60. doi: 10.1136/gut.32.9.1055. Gut. 1991. PMID: 1916491 Free PMC article. Review. No abstract available.
-
p31-43 Gliadin Peptide Forms Oligomers and Induces NLRP3 Inflammasome/Caspase 1- Dependent Mucosal Damage in Small Intestine.Front Immunol. 2019 Jan 30;10:31. doi: 10.3389/fimmu.2019.00031. eCollection 2019. Front Immunol. 2019. PMID: 30761127 Free PMC article.
-
Efficient chemo-enzymatic gluten detoxification: reducing toxic epitopes for celiac patients improving functional properties.Sci Rep. 2015 Dec 22;5:18041. doi: 10.1038/srep18041. Sci Rep. 2015. PMID: 26691232 Free PMC article.
-
Getting to grips with gluten.Gut. 2000 Dec;47(6):743-5. doi: 10.1136/gut.47.6.743. Gut. 2000. PMID: 11076867 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical